Extrapyramidal and movement disorders in diseases classified elsewhere Notes: underlying disease
G31.85 Corticobasal degeneration
Corticobasal degeneration
G37.1 Central demyelination of corpus callosum
Central demyelination of corpus callosum
G40.10 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not in…
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable Notes: Localization-related (focal) (partial) symptomatic epilepsy and ...
G40.309 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus Notes: Generalized …
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus Notes: Generalized idiopathic epilepsy and epileptic syndromes NOS
G40.B11 Juvenile myoclonic epilepsy, intractable, with status epilepticus
Juvenile myoclonic epilepsy, intractable, with status epilepticus
G40.801 Other epilepsy, not intractable, with status epilepticus Notes: Other epilepsy without intractability with status epilep…
Other epilepsy, not intractable, with status epilepticus Notes: Other epilepsy without intractability with status epilepticus
G21.0 Malignant neuroleptic syndrome Notes: code for adverse effect, if applicable, to identify drug (T43.3X5, T43.4X5, T43.50…
Malignant neuroleptic syndrome Notes: code for adverse effect, if applicable, to identify drug (T43.3X5, T43.4X5, T43.505, T43.595) ; neuroleptic induced parkinsonism (G21.11)

